McKesson (MCK) Tops Q2 EPS Views; Approves New $2B Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
McKesson Reports Fiscal 2016 Second-Quarter Results
October 29, 2015 7:30 AM EDTRevenues of $48.8 billion for the second quarter, up 10%. Second-quarter GAAP earnings per diluted share from continuing operations of $2.65, up 29%. Second-quarter Adjusted Earnings per diluted share of $3.31, up 19%. Consolidated results include a pre-tax gain of $51 million, or 14 cents per diluted share, from the sale of our ZEE Medical business. Board of Directors authorized a new $2 billion share repurchase program. Fiscal 2016 Outlook: Adjusted Earnings per diluted share of $12.50 to $13.00.
SAN... More
